Why Whole-Genome Testing Hurts More Than it Helps
By H. Gilbert Welch and Wylie Burke,
Los Angeles Times
| 04. 27. 2015
Untitled Document
President Obama proposes to plunk down $215 million on "precision medicine," and the National Institutes of Health and its National Cancer Institute will spend it by sequencing the whole genome of a million or more Americans.
Is whole-genome testing the path to health? The short answer is no.
The main problem with the proposal is that the research is bound to produce more noise than signal. The issue isn't genetics but "big" data. The basic idea of precision medicine is to look for patterns in the genome that seem to travel with problems we all care about: diabetes, heart disease, cancer and dementia. But there are a lot of possible patterns to look for.
Imagine there were only 10 data points in a person's genome and that each point could only take on one of two values: red or green. The first could be red or green, the second red or green and so forth. The number of possible patterns that could emerge from those 10 data points is 2 to the 10th power — 1,024 patterns...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
